You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昂利康(002940.SZ):子公司獲得“西咪替丁片(寵物用)”獸藥產品批准文號批件
格隆匯 02-27 16:42

格隆匯2月27日丨昂利康(002940.SZ)公佈,近日,浙江昂利康製藥股份有限公司子公司浙江昂利康動保科技有限公司(簡稱“動保科技”)收到中華人民共和國農業農村部核准簽發的“西咪替丁片(寵物用)”獸藥產品批准文號批件。

西咪替丁片的主要成份是西咪替丁,能明顯抑制晝夜基礎胃酸分泌,也能抑制由食物、組胺、五肽胃泌素、咖啡因與胰島素等誘發的胃酸分泌,用於減輕動物慢性胃炎引起的嘔吐的對症治療。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account